Skip to content

Palliative care for patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized study.

Nurse-led follow up at home or conventional medical follow-up at the outpatient clinic of patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized study comparing quality of life, satisfaction and costs.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21003
Enrollment
150
Registered
2006-05-19
Start date
2006-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Nurse led follow up at home at 2-weekly and later monthly intervals until month 13 or death versus medical follow up at the outpatient clinic at 1 month and thereafter every 2 months until month 13 or

Sponsors

Erasmus MC - University Medical Center Rotterdam Dept. Gastroenterology & Hepatology Dr. Molewaterplein 40 3015 GD Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with irresectabel of recurrent esophageal-, pancreatic- and hepatobiliary cancer, for whom no curative treatment options are available; 2. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Not able to understand or read the Dutch language; 2. Undergoing treatment with chemotherapy or radiotherapy or a combination.

Design outcomes

Primary

MeasureTime frame
Quality of life (questionnaires).

Secondary

MeasureTime frame
Patient satisfaction (questionnaire) costs.

Contacts

Public ContactP.D. Siersema

Erasmus Medical Center Department of Gastroenterology and Hepatology Room HS 512 P.O. Box 2040

p.siersema@erasmusmc.nl+31 (0)10 4632748 / +31 (0)10 4625946

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)